| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |